GMPKit Logo

Restore Operational Stability in 90-120 Days

When your pharmaceutical manufacturing operations are off-track, GMPKit deploys our proven approach to turn strategy into disciplined execution—fast.

What is GMPKit?

GMPKit restores pharmaceutical manufacturing stability using our proven 6-stage Operating Model—a disciplined framework that reduces Cost of Poor Quality (COPQ) in 90-120 days.

Learn More About GMPKit

Our Approach

When internal failure costs impact your operations, we deploy a proven operating model to restore stability in 90-120 days.

Reduction of Cost of Poor Quality (COPQ) is the lens we use to prioritize actions and measure results.

GMPKit Operating Model - COPQ-focused 4-stage roadmap showing internal failure costs across batch operations

Our operating model integrates operational diagnostics, readiness support, governance systems, and digital visibility—all measured through the Cost of Poor Quality lens to ensure every action drives measurable improvement.

Explore Further

Take the next step in understanding how GMPKit can help reduce your COPQ

Learn

How We Restore Stability in 90-120 Days

Discover our proven 4-stage operating model that turns strategy into disciplined execution

What's Costing You 15-20% of Revenue?

Understand how internal failure costs impact your operations and how to reduce them

From Crisis to Excellence: Client Journey

See how we guide pharmaceutical manufacturers from operational crisis to sustained excellence

Take Action

Calculate Your COPQ

Quantify your internal failure costs in 5 minutes

Join Our Free Newsletter

Get frameworks and insights delivered monthly

Try Our AI Learning Assistant

Ask our AI expert questions about GMP operations—get instant answers 24/7

Proven Results Across Pharmaceutical Manufacturing

We've delivered measurable results across CDMOs, biopharma sites, and advanced therapy manufacturers— restoring operational stability when it matters most.

60-80%

Backlog reduction in 90 days

20-40%

Batch success rate improvement

30-60 Days

Inspection readiness achieved

120 Days

Successful scale-up completion

Industries We Serve

Mid-Size CDMOs
Large-Scale Biopharma
Cell Therapy Operations
Gene Therapy Facilities
Protein Biologics Manufacturing

Global Experience, Local Execution:

Our team has delivered results across North America, Europe, and Asia—bringing global best practices to your local manufacturing challenges while working alongside your site teams.

Ready to Restore Operational Stability?

When your manufacturing operations are off-track and you need rapid results, let's discuss how GMPKit can deploy our proven approach to get your strategy back on track in 90-120 days.